Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
Diet and Exercise in Cystic Fibrosis
1st Edition - July 29, 2014
Editor: Ronald Ross Watson
Language: English
Hardback ISBN:9780128000519
9 7 8 - 0 - 1 2 - 8 0 0 0 5 1 - 9
eBook ISBN:9780128005880
9 7 8 - 0 - 1 2 - 8 0 0 5 8 8 - 0
Diet and Exercise in Cystic Fibrosis, a unique reference edited by distinguished and internationally recognized nutritionist and immunologist Ronald Ross Watson, fills the gap…Read more
Purchase options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Diet and Exercise in Cystic Fibrosis, a unique reference edited by distinguished and internationally recognized nutritionist and immunologist Ronald Ross Watson, fills the gap in the current dietary modalities aimed at controlling cystic fibrosis. Using expert evaluation on the latest studies of the role of food and exercise in lifelong management of cystic fibrosis, this valuable resource shows how to maintain intestinal, hepatic, and pulmonary high quality function for improving quality of life for those with cystic fibrosis. A helpful tool for researchers and clinicians alike, this reference helps refine research targets, and provides the beginning of a structured dietary management scheme for those with cystic fibrosis.
Provides a detailed resource that reviews the health problems occurring in Cystic Fibrosis relative to dietary, complementary, and alternative therapies
Contains expert evaluation on the role of foods and exercise for lifelong management of Cystic Fibrosis to maintain intestinal, hepatic, and pulmonary high quality function for improved quality of life
Defines and evaluates various nutritional and dietary approaches to the unique problems of those with Cystic Fibrosis
Respiratory / Pulmonary Researchers and Clinicians
Dedication
Preface
Acknowledgments
Biography
List of Contributors
Section A. Overview of Nutrition and Diets in Cystic Fibrosis
Chapter 1. Nutrition for Pregnant Women Who Have Cystic Fibrosis
1.1. Introduction
1.2. Historical Perspective
1.3. Nutrition: Review of the Literature
1.4. Clinical Guidance
1.5. Conclusion
Chapter 2. Disordered Eating and Body Image in Cystic Fibrosis
2.1. Introduction
2.2. Quality of Life
2.3. Body Image
2.4. Eating Behaviors
2.5. Body Dissatisfaction and Disordered Eating: Identification, Treatment, and Intervention Strategies
2.6. Conclusion
Chapter 3. Neonatal Screening and Nutrition/Growth in Cystic Fibrosis: A Review
31.3. Cystic Fibrosis–Related Diabetes: Screening and Diagnosis
31.4. Cystic Fibrosis–Related Diabetes: Treatment
31.5. Cystic Fibrosis–Related Diabetes: Comorbidity and Complications
31.6. Perspectives and Conclusions
Section F. Exercise and Behavior in Management of Cystic Fibrosis
Chapter 32. Exercise Testing in CF, the What and How
32.1. Utility of Exercise Testing
32.2. Exercise Tests
32.3. The Godfrey Protocol
32.4. The Bruce Protocol
32.5. Field Tests
32.6. Conducting an Exercise Test
32.7. Interpreting an Exercise Test
Chapter 33. Mechanisms of Exercise Limitation in Cystic Fibrosis: A Literature Update of Involved Mechanisms
33.1. Introduction
33.2. Methods
33.3. Results
33.4. Ventilatory Parameters
33.5. Muscle Function
33.6. Cardiac Constraints
33.7. Concluding Remarks
33.8. Clinical Implications
Chapter 34. Physical Activity Assessment and Impact
34.1. Introduction
34.2. Tools for Measuring Physical Activity
34.3. Normative Data for Physical Activity in CF
34.4. Methods of Analyzing and Reporting Physical Activity Data
34.5. Evidence for Impact of Physical Activity on Health of Patients with CF
34.6. Discussion
Chapter 35. Motivating Physical Activity: Skills and Strategies for Behavior Change
35.1. Beyond a Prescription
35.2. A’s of Physical Activity Counseling: A Framework for Behavior Change
35.3. Physical Activity Resources for Patients and Practitioners
Chapter 36. Diet, Food, Nutrition, and Exercise in Cystic Fibrosis
36.1. Nutrition Considerations for Exercise
36.2. Hydration Considerations for Exercise
Chapter 37. Personalizing Exercise and Physical Activity Prescriptions
37.1. Introduction
37.2. Components of a Comprehensive Exercise Prescription
37.3. Individualizing Physical Activity and Exercise Prescription for the Adult with Cystic Fibrosis
37.4. Individualizing Physical Activity and Exercise Prescription in the Child with Cystic Fibrosis
Section G. FAT and LIPID Metabolism in Cystic Fibrosis
Chapter 38. The Pancreatic Duct Ligated Pig as a Model for Patients Suffering from Exocrine Pancreatic Insufficiency—Studies of Vitamin A and E Status
38.1. Introduction
38.2. Advantages of an Animal Model to Study Effects of EPI on Vitamin Status
38.3. Effects of EPI on Serum α-Tocopherol Concentrations in Adult Minipigs, Study 1
38.4. Effects of EPI on Retinol and α-Tocopherol Concentrations in Serum and Liver Tissue of Juvenile Pigs, Study 2
38.5. Discussion
Chapter 39. Unsaturated Fatty Acids in Cystic Fibrosis: Metabolism and Therapy
39.1. Introduction
39.2. Patterns of Polyunsaturated FA Alterations in CF
39.3. Relationship between FA Alterations and Clinical Features of CF
39.4. Mechanisms of Altered FA Metabolism in CF
39.5. Dietary and Therapeutic Implications of FA Metabolism in CF
39.6. Conclusions
Chapter 40. Essential Fatty Acid Deficiency in Cystic Fibrosis: Malabsorption or Metabolic Abnormality?
40.1. Introduction
40.2. Essential Fatty Acids
40.3. Fatty Acids in Cystic Fibrosis
40.4. Issues on Obesity and How to Intervene
40.5. Conclusions
Chapter 41. Persistent Fat Malabsorption in Cystic Fibrosis
41.1. Introduction
41.2. Physiology of Intestinal Dietary Fat Absorption
41.3. Impaired Intestinal Dietary Fat Absorption in Cystic Fibrosis
41.4. Intestinal pH and Bicarbonate Secretion
41.5. Intraluminal Bile Salts
41.6. Intestinal Mucosal Abnormalities
41.7. Small Intestinal Bacterial Overgrowth
41.8. Small Intestinal Transit Time
41.9. Conclusion
Chapter 42. Omega-3 Fatty Acids and Cystic Fibrosis
42.1. Introduction
42.2. Omega-3 Fatty Acid: A Role in Cystic Fibrosis?
42.3. Omega Fatty Acids and CF: Animal Models
42.4. Omega Fatty Acids and CF: Clinical Trials
42.5. Conclusion
Index
No. of pages: 396
Language: English
Edition: 1
Published: July 29, 2014
Imprint: Academic Press
Hardback ISBN: 9780128000519
eBook ISBN: 9780128005880
RW
Ronald Ross Watson
Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models.
Affiliations and expertise
Professor, Mel and Enid Zuckerman College of Public Health and School of Medicine, Arizona Health Sciences Center, University of Arizona, Tucson, AZ, USA
Read Diet and Exercise in Cystic Fibrosis on ScienceDirect